Valuation: Cipla Limited

Market Cap 1,086B 11.28B 10.02B 9.37B 8.54B 16.07B 16.29B 113B 43.87B 553B 42.34B 41.42B 1,776B P/E 2027 *
26.2x
P/E 2028 * 21.1x
Enterprise Value 980B 10.18B 9.04B 8.45B 7.7B 14.5B 14.7B 102B 39.58B 499B 38.2B 37.37B 1,603B EV / Sales 2027 *
3.16x
EV / Sales 2028 * 2.75x
Free-Float
68.87%
Yield 2027 *
0.97%
Yield 2028 * 1.1%
1 day-0.15%
1 week-3.93%
Current month-0.15%
1 month-5.55%
3 months-7.74%
6 months+12.38%
Current year-11.07%
1 week 1,333.4
Extreme 1333.4
1,405
1 month 1,333.4
Extreme 1333.4
1,421
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 31/03/2026
Director of Finance/CFO - 23/07/2026
President - 17/05/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 24/07/2014
Director/Board Member 71 29/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%-3.93%-11.17%+13.31% 11.28B
-0.62%-2.71%+39.30%+114.07% 1,025B
-2.30%-4.44%+39.03%+66.07% 623B
-0.63%-1.96%+6.36%+74.38% 459B
-1.03%-2.82%+59.56%+39.69% 355B
-0.32%-3.36%+22.48%+40.37% 336B
-0.12%-1.52%+13.42%+26.36% 270B
-0.41%-4.35%-3.60%+9.64% 247B
-3.38%+0.30%+36.44%+51.54% 220B
-1.04%-1.46%+32.70%+96.82% 183B
Average -0.68%-2.10%+23.45%+53.23% 372.95B
Weighted average by Cap. -0.52%-2.11%+30.26%+69.34%

Financials

2027 *2028 *
Net sales 310B 3.22B 2.86B 2.67B 2.44B 4.59B 4.65B 32.34B 12.52B 158B 12.08B 11.82B 507B 347B 3.61B 3.2B 3B 2.73B 5.14B 5.21B 36.25B 14.03B 177B 13.55B 13.25B 568B
Net income 41.35B 430M 382M 357M 325M 612M 620M 4.32B 1.67B 21.06B 1.61B 1.58B 67.65B 51.42B 534M 474M 444M 404M 761M 772M 5.37B 2.08B 26.19B 2.01B 1.96B 84.12B
Net Debt -106B -1.1B -979M -915M -834M -1.57B -1.59B -11.07B -4.29B -54.02B -4.14B -4.05B -174B -131B -1.37B -1.21B -1.13B -1.03B -1.95B -1.97B -13.72B -5.31B -66.94B -5.13B -5.01B -215B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
01/10/26 ₹1,344.00 -0.15% 921,789
30/09/26 ₹1,346.00 -2.41% 1,063,964
29/09/26 ₹1,379.30 -0.32% 1,479,526
28/09/26 ₹1,383.70 -1.14% 711,020
25/09/26 ₹1,399.70 +0.05% 1,166,527
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,344.00INR
Average target price
1,509.08INR
Spread / Average Target
+12.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock